Posted by
NYC Measles Outbreak Over: Officials

NYC Measles Outbreak Over: Officials

WEDNESDAY, Sept. 4, 2019 (HealthDay News) — The New York City measles outbreak is over and the public health emergency that was declared on April 9 for parts of Brooklyn has ended, New York Mayor Bill de Blasio said Tuesday. Latest Infectious Disease News It was the largest outbreak in New York City in nearly […]

Posted by
Exercise May Be of Extra Benefit to People With Heart Disease

Exercise May Be of Extra Benefit to People With Heart Disease

Latest Heart News TUESDAY, Sept. 3, 2019 (HealthDay News) — Regular exercise benefits heart disease patients more than healthy people, according to a new study. It found that while stepping up physical activity reduced the risk of death for people with and without heart disease, those with heart disease had greatest benefit. The more they […]

Posted by
Bans Not Keeping Drivers With Implanted Defibrillators off the Road

Bans Not Keeping Drivers With Implanted Defibrillators off the Road

Latest Heart News TUESDAY, Sept. 3, 2019 (HealthDay News) — One in three patients who have implanted devices for irregular heartbeats still drive, despite being banned from getting behind the wheel, a new Danish study finds. It looked at more than 2,500 patients with implantable cardioverter defibrillators (ICDs), which deliver an electric shock to correct […]

Posted by
idarucizumab (Praxbind)

idarucizumab (Praxbind)

What is idarucizumab, and how does it work (mechanism of action)? Dabigatran prevents blood clots by binding to thrombin and preventing thrombin from combining with other proteins to form a blood clot. Dabigatran increases the risk of bleeding because it reduces the ability of blood to clot. Patients who are taking dabigatran may develop serious […]

Posted by
raltegravir (Isentress)

raltegravir (Isentress)

What is raltegravir, and how does it work (mechanism of action)? Raltegravir (Isentress) is an antiretroviral medicine approved for the treatment of human immunodeficiency virus (HIV) infection. Raltegravir is an integrase inhibitor similar to elvitegravir (Vitekta) and dolutegravir (Tivicay). Raltegravir slows the spread of HIV infection by blocking the HIV integrase enzyme required for virus […]

Posted by
Viekira Pak (ombitasvir, paritaprevir, ritonavir, and dasabuvir)

Viekira Pak (ombitasvir, paritaprevir, ritonavir, and dasabuvir)

What is Viekira Pak? What is Viekira Pak used for? Viekira Pak is a combination of drugs used to treat patients with hepatitis C virus (HCV) genotype 1. It contains four medicines, dasabuvir, ombitasvir, paritaprevir, and ritonavir. Viekira Pak belongs to a class of drugs called direct-acting antiviral agents. Similar drugs include Dasabuvir, ombitasvir, and […]

Posted by
Harvoni (ledipasvir and sofosbuvir)

Harvoni (ledipasvir and sofosbuvir)

Which drugs or supplements interact with Harvoni ? Acid reducing agents which are commonly used to treat heartburn, indigestion, and GERD may decrease the effectiveness of Harvoni treatment by decreasing blood levels of ledipasvir. Examples of acid reducing agents include antacids, histamine 2 receptor antagonists, for example, famotidine (Pepcid), and proton pump inhibitors (PPIs), for […]